Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
PLoS One
2014 Jan 01;93:e92217. doi: 10.1371/journal.pone.0092217.
Show Gene links
Show Anatomy links
Spatial and temporal control of transgene expression in zebrafish.
Akerberg AA
,
Stewart S
,
Stankunas K
.
???displayArticle.abstract???
Transgenic zebrafish research has provided valuable insights into gene functions and cell behaviors directing vertebrate development, physiology, and disease models. Most approaches use constitutive transgene expression and therefore do not provide control over the timing or levels of transgene induction. We describe an inducible gene expression system that uses new tissue-specific zebrafish transgenic lines that express the Gal4 transcription factor fused to the estrogen-binding domain of the human estrogen receptor. We show these Gal4-ERT driver lines confer rapid, tissue-specific induction of UAS-controlled transgenes following tamoxifen exposure in both embryos and adult fish. We demonstrate how this technology can be used to define developmental windows of gene function by spatiotemporal-controlled expression of constitutively active Notch1 in embryos. Given the array of existing UAS lines, the modular nature of this system will enable many previously intractable zebrafish experiments.
???displayArticle.pubmedLink???
24643048
???displayArticle.pmcLink???PMC3958484 ???displayArticle.link???PLoS One ???displayArticle.grants???[+]
Figure 2. The Gal4-ERT system provides rapid induction of gene expression.(A–D) Kinetics of EGFP expression in Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) animals upon administration of 2 μM 4-OHT at 24 hpf for 0–4.5 hours. (A′–D′) High magnification images demonstrating EGFP expression for each treatment. White arrowheads point to epidermal expression of EGFP; blue arrows indicate bleed-through from the heartmuscle-specific ECFP transgenesis marker.
Figure 3. Transgene expression levels depend upon 4-OHT dosage.(A–D) EGFP expression upon treatment of Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) zebrafish with ethanol or the indicated dose of 4-OHT from 4–24 hpf. The blue arrow indicates myl7:ECFP expression. (A′–D′) High-magnification images of ventralepidermis from fish in each treatment group. (E) Normalized EGFP intensity (to the 0.5 μM 4-OHT treated group) of fish treated with ethanol or 4-OHT. Error bars represent standard deviations.
Figure 4. Inducible transgene expression in adult zebrafish.(A–D) Expression of EGFP in the eye of a single adult Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) zebrafish prior to (A and B) and after (C and D) treatment with 1 μM tamoxifen for one hour per day for three consecutive days. Green arrows point to EGFP expression in the eye. The areas bounded by the dashed red box in A and C are shown at high magnification in B and D, respectively. (E–H) Immunostaining of paraffin sections with anti-EGFP antibodies (shown in green) in eyes from DMSO- (E and F) and tamoxifen-treated (G and H) Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) fish. Panels F and H show overlays with anti-EGFP antibody staining in green, Hoechst-stained nuclei in blue, and auto-fluorescence in red. Fish were drug treated as in A–D. Green arrows indicate EGFP expression in photoreceptors and asterisks (*) denote auto-fluorescence in photoreceptor outer segments. (I) In situ hybridization for EGFP mRNA in a paraffin section from a 4-OHT treated Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) animal. The blue arrow shows EGFP expression in photoreceptors.
Figure 5. Overexpression of the Notch1 intracellular domain using the dusp6:Gal4-ERT driver disrupts notochord development.(A and B) EGFP expression at the 10-somite stage in control (A) and 2 μM 4-OHT treated Tg(dusp6:Gal4-ERT-VP16; UAS:EGFP) fish. The green arrow points to EGFP expression at the midline. (C–F) DIC images of control (C and D) and 4-OHT treated (4 μM from 2–24 hpf, E and F) Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) animals at 24 hpf. Regions bounded by the dashed red box in panels C and E are shown in high magnification in panels D and F, respectively. In panel D, the red arrow indicates the floor plate (fp) and the blue arrow indicates the notochord (nc); in panel E, the magenta arrow highlights the reduced notochord and disorganized floor plate.
Figure 6. Using inducible expression to define temporal roles of Notch1 signaling in notochord development.(A–E) Expression of myc-tagged NICD by immunostaining with myc antibodies on 24 hpf Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) embryos treated with ethanol (A) or 4 μM 4-OHT at the indicated times (B–E). Blue arrows indicate myocardial ECFP expression to mark transgenic animals and magenta arrows show expression of myc-tagged NICD. Panel insets display high magnification images of boxed regions where red arrows indicate the notochord (A and E) and the missing notochord (B–D). (F) Normalized penetrance of notochord defects in Tg(dusp6:Gal4-ERT-VP16; UAS:NICD) animals treated with 4-OHT at the indicated stages of development. Each data point represents the normalized fraction of affected animals in sets of treated embryos from four independent clutches. The data is normalized to the average fraction of abnormal fish in the four 4–24 h sets. The double asterisk indicates a significant difference between 4–24 h and 10–24 h 4-OHT treated fish (P<0.005). (G–I) Expression of shha in the floor plate of animals treated with ethanol (G) or with 4-OHT for the indicated times (H–I). Boxed regions are shown at higher magnification in the panel insets. Red arrows indicate shha expressing floor plate cells.
Figure 1. Temporally and spatially controlled transgene expression in zebrafish.(A) Schematic of transgenic constructs used in the Gal4-ERT system. A tamoxifen-responsive Gal4-ERT-VP16 construct is expressed from a tissue-specific promoter that activates any UAS-linked responder line (shown here as a 5xUAS:EGFP reporter) upon tamoxifen or 4-OHT exposure (orange squares). The myl7:ECFP cassette serves as a transgenesis marker for the Gal4-ERT lines. (B–D) Visualization of EGFP expression in Tg(krt5:Gal4-ERT-VP16; UAS:EGFP) animals treated with ethanol (B) or 2 μM 4-OHT (C and D) from 4–24 hpf. The white arrow in panel D highlights expression of EGFP in the epidermis. (E–I) EGFP expression in Tg(dusp6:Gal4-ERT-VP16; UAS:EGFP) animals treated with vehicle (E) or 2 μM 4-OHT (F-I) from 4–24 hpf. In panels G and H, the white arrow indicates EGFP expression in the hindbrain and midbrain-hindbrain boundary. In panel I, arrowheads mark dorsal spinal cord neurons and the arrow points to EGFP expression in the floor plate. (J–M) Expression of EGFP in control (J) and 4-OHT treated (2 μM, K-M) Tg(ef1α:Gal4-ERT-VP16; UAS:EGFP) animals in a variety of cell types throughout the embryo including skeletal muscle (K, white arrow), the eye (L, white arrow), and the midbrain/midbrain-hindbrain boundary (M, white arrow). In panels B, E, and J, blue arrows point to myocardial ECFP expression, which represents the marker for transgenesis and serves as an internal control.
Appel,
Delta-mediated specification of midline cell fates in zebrafish embryos.
1999, Pubmed
Appel,
Delta-mediated specification of midline cell fates in zebrafish embryos.
1999,
Pubmed
Asakawa,
Genetic dissection of neural circuits by Tol2 transposon-mediated Gal4 gene and enhancer trapping in zebrafish.
2008,
Pubmed
Brand,
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.
1993,
Pubmed
Coffman,
Expression of an extracellular deletion of Xotch diverts cell fate in Xenopus embryos.
1993,
Pubmed
,
Xenbase
Danielian,
Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen.
1993,
Pubmed
Echelard,
Sonic hedgehog, a member of a family of putative signaling molecules, is implicated in the regulation of CNS polarity.
1993,
Pubmed
Feil,
Regulation of Cre recombinase activity by mutated estrogen receptor ligand-binding domains.
1997,
Pubmed
Fischer,
GAL4 activates transcription in Drosophila.
1988,
Pubmed
Gemberling,
The zebrafish as a model for complex tissue regeneration.
2013,
Pubmed
Gerety,
An inducible transgene expression system for zebrafish and chick.
2013,
Pubmed
Giniger,
Specific DNA binding of GAL4, a positive regulatory protein of yeast.
1985,
Pubmed
Grunwald,
Headwaters of the zebrafish -- emergence of a new model vertebrate.
2002,
Pubmed
Halloran,
Laser-induced gene expression in specific cells of transgenic zebrafish.
2000,
Pubmed
Halpern,
Gal4/UAS transgenic tools and their application to zebrafish.
2008,
Pubmed
Kakidani,
GAL4 activates gene expression in mammalian cells.
1988,
Pubmed
Knopf,
Dually inducible TetON systems for tissue-specific conditional gene expression in zebrafish.
2010,
Pubmed
Krauss,
A functionally conserved homolog of the Drosophila segment polarity gene hh is expressed in tissues with polarizing activity in zebrafish embryos.
1993,
Pubmed
Kwan,
The Tol2kit: a multisite gateway-based construction kit for Tol2 transposon transgenesis constructs.
2007,
Pubmed
Latimer,
Notch signaling regulates midline cell specification and proliferation in zebrafish.
2006,
Pubmed
Laughon,
Primary structure of the Saccharomyces cerevisiae GAL4 gene.
1984,
Pubmed
Lieber,
Antineurogenic phenotypes induced by truncated Notch proteins indicate a role in signal transduction and may point to a novel function for Notch in nuclei.
1993,
Pubmed
Lin,
GAL4 derivatives function alone and synergistically with mammalian activators in vitro.
1988,
Pubmed
Louvion,
Fusion of GAL4-VP16 to a steroid-binding domain provides a tool for gratuitous induction of galactose-responsive genes in yeast.
1993,
Pubmed
Ma,
Deletion analysis of GAL4 defines two transcriptional activating segments.
1987,
Pubmed
Ma,
Yeast activators stimulate plant gene expression.
1988,
Pubmed
Melby,
Specification of cell fates at the dorsal margin of the zebrafish gastrula.
1996,
Pubmed
Molina,
Generation of FGF reporter transgenic zebrafish and their utility in chemical screens.
2007,
Pubmed
Pan,
Zebrabow: multispectral cell labeling for cell tracing and lineage analysis in zebrafish.
2013,
Pubmed
Rebay,
Specific truncations of Drosophila Notch define dominant activated and dominant negative forms of the receptor.
1993,
Pubmed
Sadowski,
GAL4-VP16 is an unusually potent transcriptional activator.
1988,
Pubmed
Scheer,
Use of the Gal4-UAS technique for targeted gene expression in the zebrafish.
1999,
Pubmed
Scott,
The Gal4/UAS toolbox in zebrafish: new approaches for defining behavioral circuits.
2009,
Pubmed
Stewart,
Limited dedifferentiation provides replacement tissue during zebrafish fin regeneration.
2012,
Pubmed
Struhl,
Intrinsic activity of the Lin-12 and Notch intracellular domains in vivo.
1993,
Pubmed
Thisse,
High-resolution in situ hybridization to whole-mount zebrafish embryos.
2008,
Pubmed
Tsang,
A role for MKP3 in axial patterning of the zebrafish embryo.
2004,
Pubmed
Urasaki,
Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition.
2006,
Pubmed
Wang,
A regulatory system for use in gene transfer.
1994,
Pubmed
Wang,
Spatiotemporal expression of zebrafish keratin 18 during early embryogenesis and the establishment of a keratin 18:RFP transgenic line.
2006,
Pubmed
Wang,
Epidermis-restricted expression of zebrafish cytokeratin II is controlled by a -141/+85 minimal promoter, and cassette -141/-111 is essential for driving the tissue specificity.
2006,
Pubmed
Webster,
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function.
1988,
Pubmed
Yamamoto,
Mib-Jag1-Notch signalling regulates patterning and structural roles of the notochord by controlling cell-fate decisions.
2010,
Pubmed